FDA Determines Regulatory Review Period for RAINDROP NEAR VISION INLAY Patent Extension

Summary

The U.S. Food and Drug Administration (FDA) has officially confirmed the regulatory review period for RAINDROP NEAR VISION INLAY, a medical device, in accordance with federal regulations, following a submission to the U.S. Patent and Trademark Office (USPTO) for patent extension.